TRUSEQ
Live / Registered — Registered and renewed (as of 05 Oct 2021)
What this means for you
Registered since 29 Nov 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Nov 2021).
Record
- Serial number
- 85975751
- Registration number
- 4064847
- Mark type
- Stylized text
- Filed
- 23 Jul 2010
- Published for opposition
- 26 Apr 2011
- Registered
- 29 Nov 2011
- Next maintenance due
- 29 Nov 2021
- Attorney of record
- Susan M. Natland
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits comprising nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research
Owner
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
Prosecution history
- 29 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Oct 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 05 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 May 2021 — TEAS SECTION 8 & 9 RECEIVED
- 29 Nov 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Oct 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED